🔗 Share this article

The top legal official in Texas Paxton is suing the makers of Tylenol, claiming the firms withheld safety concerns that the pain reliever created to children's cognitive development.

The court filing follows thirty days after Former President Trump publicized an unproven link between taking Tylenol - also known as acetaminophen - throughout gestation and autism in young ones.

Paxton is filing suit against Johnson & Johnson, which formerly manufactured the medication, the only pain reliever suggested for expectant mothers, and Kenvue, which presently makes it.

In a declaration, he claimed they "misled consumers by profiting off of suffering and promoting medication ignoring the dangers."

Kenvue says there is insufficient reliable data tying acetaminophen to autism.

"These companies lied for decades, deliberately risking countless individuals to boost earnings," the attorney general, from the Republican party, declared.

The manufacturer commented that it was "seriously troubled by the spread of false claims on the safety of paracetamol and the likely effects that could have on the well-being of women and children in America."

On its website, the company also mentioned it had "continuously evaluated the applicable studies and there is lacking reliable evidence that demonstrates a verified association between taking paracetamol and autism spectrum disorder."

Associations acting on behalf of medical professionals and healthcare providers share this view.

ACOG has said acetaminophen - the primary component in acetaminophen - is one of the few options for expectant mothers to address discomfort and elevated temperature, which can pose serious health risks if ignored.

"In over twenty years of studies on the consumption of acetaminophen in gestation, not a single reputable study has definitively established that the consumption of acetaminophen in any period of gestation results in neurodevelopmental disorders in children," the organization commented.

The lawsuit references current declarations from the Trump administration in claiming the drug is allegedly unsafe.

In recent weeks, Trump caused concern from medical authorities when he advised women during pregnancy to "struggle intensely" not to take acetaminophen when ill.

The US Food and Drug Administration then released a statement that doctors should consider limiting the use of acetaminophen, while also stating that "a direct connection" between the medication and autism in minors has not been proven.

The Health Department head Robert F Kennedy Jr, who oversees the FDA, had promised in spring to initiate "extensive scientific investigation" that would identify the origin of autism spectrum disorder in a limited time.

But authorities advised that finding a single cause of autism - thought by researchers to be the consequence of a complicated interplay of genetic and environmental factors - would be difficult.

Autism is a form of permanent neurological difference and disability that affects how individuals perceive and interact with the world, and is diagnosed using doctors' observations.

In his lawsuit, Paxton - who supports Trump who is campaigning for the Senate - claims the manufacturer and Johnson & Johnson "willfully ignored and tried to quiet the evidence" around acetaminophen and autism.

The case seeks to make the corporations "remove any marketing or advertising" that asserts acetaminophen is reliable for women during pregnancy.

The court case mirrors the concerns of a collection of mothers and fathers of young ones with autism spectrum disorder and ADHD who took legal action against the makers of Tylenol in recently.

Judicial authorities dismissed the legal action, saying investigations from the parents' expert witnesses was not conclusive.